Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | IWR-1 |
| Trade Name | |
| Synonyms | IWR-1-endo |
| Drug Descriptions |
IWR-1 selectively inhibits Wnt/beta-catenin mediated signaling by inhibiting tankyrase1/2, thus stabilizing Axin and stimulating beta-catenin degradation (PMID: 23621985, PMID: 31452704). |
| DrugClasses | Tankyrase Inhibitor 11 |
| CAS Registry Number | 1127442-82-3 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Everolimus + IWR-1 | Everolimus IWR-1 | 0 | 0 |
| IWR-1 | IWR-1 | 8 | 0 |